Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Biophysical Reviews|May 16, 2025
Effects of ionizing radiations of different qualities and delivery types on blood cellsAnalía Inés Alet, Sabrina Porini, Bibiana Doris Riquelme, et al.Journal of Translational Medicine|September 16, 2024
The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytesJürgen Borlak, Yari Ciribilli, Alessandra Bisio, et al.Plos One|July 18, 2013
P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elementsIvan Raimondi, Yari Ciribilli, Paola Monti, et al.Frontiers in Immunology|February 22, 2017
The Immunoregulatory Potential of Particle Radiation in Cancer TherapyDaniel K Ebner, Walter Tinganelli, Alexander Helm, et al.Oncotarget|June 14, 2014
∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sitesPaola Monti, Yari Ciribilli, Alessandra Bisio, et al.Cell Cycle (Georgetown, Tex.)|March 23, 2013
Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeuticsMattia Lion, Alessandra Bisio, Toma Tebaldi, et al.BMC Cancer|November 22, 2013
Identification of new p53 target microRNAs by bioinformatics and functional analysisAlessandra Bisio, Veronica De Sanctis, Valerio Del Vescovo, et al.International Journal of Particle Therapy|November 28, 2019
Combining Heavy-Ion Therapy with Immunotherapy: An Update on Recent DevelopmentsAlexander Helm, Daniel K Ebner, Walter Tinganelli, et al.Plos One|December 8, 2017
Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer developmentWilliam Bruno, Virginia Andreotti, Alessandra Bisio, et al.Cancers|April 14, 2026
p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code?Laura Bartolomei, Beatrice Pretto, Samuele Brugnara, et al.Pageof 5